BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 772839)

  • 1. The relative susceptibility of New Zealand black and CBA mice to infection with opportunistic fungal pathogens.
    Corbel MJ; Eades SM
    Sabouraudia; 1976 Mar; 14(1):17-32. PubMed ID: 772839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fungi pathogenic to humans: molecular bases of virulence of Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus.
    Karkowska-Kuleta J; Rapala-Kozik M; Kozik A
    Acta Biochim Pol; 2009; 56(2):211-24. PubMed ID: 19543556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic characterization of some potentially pathogenic mucoraceous fungi.
    Hessian PA; Smith JM
    Sabouraudia; 1982 Sep; 20(3):209-16. PubMed ID: 6182620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human fungal pathogens: Why should we learn?
    Kim JY
    J Microbiol; 2016 Mar; 54(3):145-8. PubMed ID: 26920875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative ocular pathogenicity of Cryptococcus neoformans, Candida glabrata, and Aspergillus fumigatus in the rabbit.
    Fujita NK; Henderson DK; Hockey LJ; Guze LB; Edwards JE
    Invest Ophthalmol Vis Sci; 1982 Mar; 22(3):410-4. PubMed ID: 7037676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental animal studies with antimycotic substances. Part 2. Comparative studies on the effectiveness of peroral and subcutaneous application of amphotericin B on an experimental model of mice infected with Candida albicans, Cryptococcus neoformans, Mucor pusillus or Aspergillus fumigatus].
    OSSWALD H; SEELIGER HP
    Z Immun exp ther; 1960 Feb; 119():161-74. PubMed ID: 14429266
    [No Abstract]   [Full Text] [Related]  

  • 7. Overview of selected virulence attributes in Aspergillus fumigatus, Candida albicans, Cryptococcus neoformans, Trichophyton rubrum, and Exophiala dermatitidis.
    Boral H; Metin B; Döğen A; Seyedmousavi S; Ilkit M
    Fungal Genet Biol; 2018 Feb; 111():92-107. PubMed ID: 29102684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Are there pathogenicity factors in fungi?].
    Morschhäuser J; Köhler G; Hacker J
    Mycoses; 1996; 39 Suppl 1():51-4. PubMed ID: 8767271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparative virulence of thermotolerant Mucorales species in mice.
    Kitz DJ; Embree RW; Cazin J
    Mycopathologia; 1983 Apr; 82(1):17-22. PubMed ID: 6877338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of current genome projects on the study of pathogenic and allergenic fungi.
    Breitenbach M; Crameri R; Lehrer SB
    Chem Immunol; 2002; 81():5-9. PubMed ID: 12102005
    [No Abstract]   [Full Text] [Related]  

  • 11. Counterimmunoelectrophoresis and opportunistic fungal infections.
    Smith JM
    Mycopathologia; 1977 Feb; 60(2):99-104. PubMed ID: 321971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis I: interactions of host cells and fungi.
    Clemons KV; Calich VL; Burger E; Filler SG; Grazziutti M; Murphy J; Roilides E; Campa A; Dias MR; Edwards JE; Fu Y; Fernandes-Bordignon G; Ibrahim A; Katsifa H; Lamaignere CG; Meloni-Bruneri LH; Rex J; Savary CA; Xidieh C
    Med Mycol; 2000; 38 Suppl 1():99-111. PubMed ID: 11204170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a real-time impedance analysis platform on fungal infection.
    Sun J; Ning D; Cai W; Zhou H; Zhang H; Guan D; Wu D
    J Microbiol Methods; 2017 May; 136():88-93. PubMed ID: 28323067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins.
    Noverr MC; Phare SM; Toews GB; Coffey MJ; Huffnagle GB
    Infect Immun; 2001 May; 69(5):2957-63. PubMed ID: 11292712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infection.
    Lewis RE; Liao G; Wang W; Prince RA; Kontoyiannis DP
    Virulence; 2011; 2(4):348-55. PubMed ID: 21788730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis and epidemiology of opportunistic mycotic infections: a review.
    Rippon JW
    Am J Med Technol; 1977 Mar; 43(3):226-8. PubMed ID: 848497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diverse roles of autophagy in medically important fungi.
    Palmer GE; Askew DS; Williamson PR
    Autophagy; 2008 Nov; 4(8):982-8. PubMed ID: 18927489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical identification of aetiological agents of systemic bovine zygomycosis.
    Jensen HE; Aalbaek B; Schønheyder H
    J Comp Pathol; 1994 Jan; 110(1):65-77. PubMed ID: 8040374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.
    Pfaller MA; Diekema DJ
    J Clin Microbiol; 2004 Oct; 42(10):4419-31. PubMed ID: 15472288
    [No Abstract]   [Full Text] [Related]  

  • 20. Candida albicans, Cryptococcus neoformans or Aspergillus fumigatus induces an antifungal activity in mouse serum, which is different from transferrin.
    OKAZAKI K; ASAKURA M; SUGIMOTO N; HINENOYA A; YAMASAKI S
    J Vet Med Sci; 2009 Nov; 71(11):1459-64. PubMed ID: 19959896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.